Millions face debilitating hearing loss, tinnitus, and vertigo, but a medical breakthrough could soon offer true recovery. Trey speaks with ENT expert and CEO of Sound Pharmaceuticals, Dr. Jonathan Kil, to unpack the alarming connection between untreated hearing loss and dementia risk. Dr. Kil shares his personal experience with severe vertigo and details the 25-year journey behind SPI-1005, a landmark oral drug targeting Meniere's disease. Learn more about your ad choices. Visit podcastchoices.com/adchoices
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from The Trey Gowdy Podcast
Q & Trey: Should We Worry About AI?
Q & Trey: How Should a Jury Handle a Mental Health Defense?
There Is A Time For Everything
Q & Trey: The DOJ and Rebuilding Public Trust
Get summaries like this every morning.
Free AI-powered recaps of The Trey Gowdy Podcast and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.